CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 238 enrolled
Drug / intervention
Polymotion Hip Resurfacing (PHR) Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06792539
NCT06792539N/AActive
CompareCT.gov

A Multi-Center, Prospective, Non-Randomized, Pivotal Trial Evaluating the Safety and Effectiveness of the Polymotion Hip Resurfacing System

JointMedica Inc.·interventional·Posted Jan 24, 2025·Updated May 1, 2026

In Brief

A clinical study evaluating Polymotion Hip Resurfacing (PHR) System for Osteoarthritis of the Hip and 2 related conditions. Active but no longer recruiting, targeting 238 participants across 9 sites in 2 countries.

Detailed Summary

The goal of this clinical trial is to evaluate the safety and effectiveness of the Polymotion Hip Resurfacing (PHR) System compared to total hip arthroplasty, for adults who require hip resurfacing arthroplasty due to 1) non-inflammatory arthritis (degenerative joint disease) such as osteoarthritis, traumatic arthritis, or 2) mild dysplasia/developmental dislocation of the hip (DDH) up to Crowe Grade 1.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis of the Hip, Degenerative Joint Disease of Hip, Dysplasia; Hip
CountriesBermuda, United States
Collaborators--

Timeline

N/AActive
2025202620272028
First PostedJan 24, 2025
Enrollment StartJan 22, 2025
Primary CompletionApr 1, 2028
Study CompletionJun 1, 2028
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 1.4 years agoPrimary completion in 1.7 years

Interventions

Polymotion Hip Resurfacing (PHR) Systemdevice

Surgical